Infectious Diseases E-Book - Elsevier eLibrary

「重要なお知らせ:日本語書籍をご購入いただき、eLibraryをご利用の皆さまへ」
エルゼビアは、より快適にサービスをご利用いただくため、システムの重要なアップデートを実施いたします。
現在eLibraryで日本語電子書籍をご利用のお客様は、今後より高いアクセシビリティとセキュリティを備えた新しいプラットフォーム「eBooks+」へアカウントが2025年11月中旬から下旬に移行されます。
お客様ご自身でのお手続きは不要です。ご利用中のコンテンツはすべて自動的に移行され、移行作業が完了次第、自動的にeBooks+へリダイレクトされます。

 Japanese    English

Please enter AND, OR, NOT to narrow your search results
 
 
 

Infectious Diseases E-Book

0 stars out of 5(0 rating)
Format : eBook
Read this on :
 

Book Description

Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. Extensively updated, the fourth edition includes brand-new information on advances in diagnosis of infection; Hepatitis C; managing resistant bacterial infections; and many other timely topics. An abundance of photographs and illustrations; a practical, clinically-focused style; highly-templated organization; and robust interactive content combine to make this clinician-friendly resource the fastest and best place to find all of the authoritative, current information you need.

 

 

 

  • Hundreds of full-color photographs and figures provide unparalleled visual guidance.
  • Consistent chapter organization and colorful layouts make for quick searches.
  • Clinically-focused guidance from "Practice Points" demonstrates how to diagnose and treat complicated problems encountered in practice.
  • The "Syndromes by Body System", "HIV and AIDS", and "International Medicine" sections are designed to reflect how practicing specialists think when faced with a patient.
  • Sweeping updates include new or revised chapters on:

     

     

     

     

    • Hepatitis C and antivirals
    • Fungal infection and newer antifungals
    • Microbiome and infectious diseases as well as advances in diagnosis of infection; Clostridium difficile epidemiology; infection control in the ICU setting; Chlamydia trachomatis infection; acquired syndromes associated with autoantibodies to cytokines;; management of multidrug resistant pathogens; probiotics, polymyxins, and the pathway to developing new antibiotics
    • HIV including HIV and aging, antiretroviral therapy in developing countries, and cure for HIV